5-Methyl-2-(tributylstannyl)pyridine
Product Information
Molecular Formula
C18H33NSn
Molecular Weight
382.16
Description
Used in Stille cross coupling reactions.
Synonyms
Tributyl-(5-methylpyridin-2-yl)stannane
IUPAC Name
tributyl-(5-methylpyridin-2-yl)stannane
SMILES
CCCC[Sn](CCCC)(CCCC)C1=NC=C(C=C1)C
InChI
InChI=1S/C6H6N.3C4H9.Sn/c1-6-3-2-4-7-5-63*1-3-4-2/h2-3,5H,1H33*1,3-4H2,2H3
InChI Key
MVOHAZAWWAXIDR-NMORFHBLAZ
Flash Point
Not applicable
Purity
94%
Density
1.106 g/mL at 25 °C
Storage
2-8°C
Refractive Index
n20/D 1.514
Safety Information
Hazards
H301 - H312 - H315 - H319 - H372 - H410
Precautionary Statement
P273 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P305 + P351 + P338 - P314
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Rotatable Bond Count
10
Exact Mass
383.163503 g/mol
Monoisotopic Mass
383.163503 g/mol
Topological Polar Surface Area
12.9Ų
Heavy Atom Count
20
Formal Charge
0
Complexity
220
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021222363-A1 | Cycloalkyl pyrimidines as ferroportin inhibitors | 2020-04-28 |
| WO-2021222483-A1 | Methods of use for pyrimidines as ferroportin inhibitors | 2020-04-28 |
| WO-2021102288-A1 | Pyridopyrimidinone derivatives as ahr antagonists | 2019-11-22 |
| WO-2021070132-A1 | Bi-aryl dihydroorotate dehydrogenase inhibitors | 2019-10-10 |
| WO-2020239951-A1 | Amino quinazoline derivatives as p2x3 inhibitors | 2019-05-31 |
| WO-2020239953-A1 | Pyridopyrimidines derivatives as p2x3 inhibitors | 2019-05-31 |
| AU-2020281923-A1 | Amino quinazoline derivatives as P2X3 inhibitors | 2019-05-31 |
| AU-2020281924-A1 | Pyridopyrimidines derivatives as P2X3 inhibitors | 2019-05-31 |
| CA-3139018-A1 | Amino quinazoline derivatives as p2x3 inhibitors | 2019-05-31 |
| KR-20220016074-A | Pyridopyrimidine derivatives as P2X3 inhibitors | 2019-05-31 |
